108 related articles for article (PubMed ID: 27400993)
41. Chimeras containing influenza NS1 and HIV-1 Rev protein sequences: mechanism of their inhibition of nuclear export of Rev protein-RNA complexes.
Chen Z; Li Y; Krug RM
Virology; 1998 Feb; 241(2):234-50. PubMed ID: 9499798
[TBL] [Abstract][Full Text] [Related]
42. To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1.
Weber-Gerlach M; Weber F
J Virol; 2016 Oct; 90(19):8389-94. PubMed ID: 27440898
[TBL] [Abstract][Full Text] [Related]
43. Long-term adaptation following influenza A virus host shifts results in increased within-host viral fitness due to higher replication rates, broader dissemination within the respiratory epithelium and reduced tissue damage.
Amat JAR; Patton V; Chauché C; Goldfarb D; Crispell J; Gu Q; Coburn AM; Gonzalez G; Mair D; Tong L; Martinez-Sobrido L; Marshall JF; Marchesi F; Murcia PR
PLoS Pathog; 2021 Dec; 17(12):e1010174. PubMed ID: 34919598
[TBL] [Abstract][Full Text] [Related]
44. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.
Twu KY; Noah DL; Rao P; Kuo RL; Krug RM
J Virol; 2006 Apr; 80(8):3957-65. PubMed ID: 16571812
[TBL] [Abstract][Full Text] [Related]
45. Structure and Function of the Influenza A Virus Non-Structural Protein 1.
Han CW; Jeong MS; Jang SB
J Microbiol Biotechnol; 2019 Aug; 29(8):1184-1192. PubMed ID: 31154753
[TBL] [Abstract][Full Text] [Related]
46. The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways.
Tisoncik JR; Billharz R; Burmakina S; Belisle SE; Proll SC; Korth MJ; García-Sastre A; Katze MG
J Gen Virol; 2011 Sep; 92(Pt 9):2093-2104. PubMed ID: 21593271
[TBL] [Abstract][Full Text] [Related]
47. Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-94.
Guo Y; Wang M; Zheng GS; Li WK; Kawaoka Y; Webster RG
J Gen Virol; 1995 Aug; 76 ( Pt 8)():2009-14. PubMed ID: 7636481
[TBL] [Abstract][Full Text] [Related]
48. Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines.
Shi S; Chen S; Han W; Wu B; Zhang X; Tang Y; Wang X; Zhu Y; Peng D; Liu X
Vaccine; 2016 Jan; 34(3):350-7. PubMed ID: 26638027
[TBL] [Abstract][Full Text] [Related]
49. Modeling within-host dynamics of influenza virus infection including immune responses.
Pawelek KA; Huynh GT; Quinlivan M; Cullinane A; Rong L; Perelson AS
PLoS Comput Biol; 2012; 8(6):e1002588. PubMed ID: 22761567
[TBL] [Abstract][Full Text] [Related]
50. Isolation and characterisation of an H3N8 equine influenza virus in Australia, 2007.
Watson J; Halpin K; Selleck P; Axell A; Bruce K; Hansson E; Hammond J; Daniels P; Jeggo M
Aust Vet J; 2011 Jul; 89 Suppl 1():35-7. PubMed ID: 21711282
[TBL] [Abstract][Full Text] [Related]
51. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway.
Min JY; Krug RM
Proc Natl Acad Sci U S A; 2006 May; 103(18):7100-5. PubMed ID: 16627618
[TBL] [Abstract][Full Text] [Related]
52. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
Min JY; Li S; Sen GC; Krug RM
Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
[TBL] [Abstract][Full Text] [Related]
53. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A
J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798
[TBL] [Abstract][Full Text] [Related]
54. Attenuated influenza virus vaccines with modified NS1 proteins.
Richt JA; García-Sastre A
Curr Top Microbiol Immunol; 2009; 333():177-95. PubMed ID: 19768406
[TBL] [Abstract][Full Text] [Related]
55. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5.
Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477
[TBL] [Abstract][Full Text] [Related]
56. Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response.
Feng W; Sun X; Shi N; Zhang M; Guan Z; Duan M
Biochem Biophys Res Commun; 2017 Jan; 482(4):1107-1113. PubMed ID: 27914808
[TBL] [Abstract][Full Text] [Related]
57. Antigenic and genetic analysis of H3N8 influenza viruses isolated from horses in Japan and Mongolia, and imported from Canada and Belgium during 2007-2010.
Motoshima M; Okamatsu M; Asakura S; Kuribayashi S; Sengee S; Batchuluun D; Ito M; Maeda Y; Eto M; Sakoda Y; Sodnomdarjaa R; Kida H
Arch Virol; 2011 Aug; 156(8):1379-85. PubMed ID: 21505822
[TBL] [Abstract][Full Text] [Related]
58. Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions.
Aramini JM; Ma LC; Zhou L; Schauder CM; Hamilton K; Amer BR; Mack TR; Lee HW; Ciccosanti CT; Zhao L; Xiao R; Krug RM; Montelione GT
J Biol Chem; 2011 Jul; 286(29):26050-60. PubMed ID: 21622573
[TBL] [Abstract][Full Text] [Related]
59. Influenza A virus lacking the effector and C terminal domains of NS1 protein induces cytokines associated with high pathogenicity in mice.
Turianová L; Lachová V; Beňová K; Kostrábová A; Betáková T
Acta Virol; 2020; 64(1):78-87. PubMed ID: 32180421
[TBL] [Abstract][Full Text] [Related]
60. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses.
Yin C; Khan JA; Swapna GV; Ertekin A; Krug RM; Tong L; Montelione GT
J Biol Chem; 2007 Jul; 282(28):20584-92. PubMed ID: 17475623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
